PROCEPT BioRobotics Corporation (NASDAQ: PRCT) reported Q3 EPS of ($0.51), $0.01 worse than the analyst estimate of ($0.50). Revenue for the quarter came in at $20.3 million versus the consensus estimate of $16.79 million.

GUIDANCE:

PROCEPT BioRobotics Corporation sees FY2022 revenue of $72.5 million.

For earnings history and earnings-related data on PROCEPT BioRobotics Corporation (PRCT) click here.